Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EV50 of 0.2% ropivacaine for ultrasound-guided median nerve block in pediatric trigger finger surgery
ChiCTR2000035157Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in trigger finger, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: MEC90 of ropivacaine, MEV90 of ropivacaine and 1 more. Started Aug 2020; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
trigger finger
Beyond the preview
Go deeper on ChiCTR2000035157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035157.